Cargando…
Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours
Non-functioning pituitary tumours (NF-PitNETs) are common intracranial benign neoplasms that can exhibit aggressive behaviour by invading neighbouring structures and, in some cases, have multiple recurrences. Despite resulting in severe co-morbidities, no predictive biomarkers of recurrence have bee...
Autores principales: | Rai, Ashutosh, Yelamanchi, Soujanya D., Radotra, Bishan D., Gupta, Sunil K., Mukherjee, Kanchan K., Tripathi, Manjul, Chhabra, Rajesh, Ahuja, Chirag K., Kumar, Narendra, Pandey, Akhilesh, Korbonits, Márta, Dutta, Pinaki, Gaston-Massuet, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482208/ https://www.ncbi.nlm.nih.gov/pubmed/36114575 http://dx.doi.org/10.1186/s40478-022-01441-5 |
Ejemplares similares
-
ODP368 Hyper-phosphorylation of β-catenin at Serine552: predictive marker of invasion and recurrence of Non-Functioning Pituitary Tumours (NFPTs)
por: Rai, Ashutosh, et al.
Publicado: (2022) -
Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas
por: Rai, Ashutosh, et al.
Publicado: (2021) -
Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence
por: Das, Liza, et al.
Publicado: (2021) -
Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021) -
Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes
por: Das, Liza, et al.
Publicado: (2021)